Healthcare ❯Disease Prevention

Vaccination

Flu Vaccine Immunization Influenza Vaccine Mpox Vaccine DTaP Vaccine Measles Vaccine Public Health Initiatives Mpox Infectious Disease Control Seasonal Flu Vaccine Public Health Response Respiratory Infections Public Health Alerts Measles Flu Vaccination MMR Vaccine BCG Vaccine COVID-19 Vaccines H5N1 Vaccines Elderly Care RSV Autism Research RSV Vaccines Mpox Vaccination Whooping Cough Vaccine Vaccine Shortage Mpox Vaccines Vaccine Development

French Authorities Exclude Seniors from Chikungunya Vaccination After Serious Adverse Events

Following three severe reactions, including one death, those aged 65 and older are no longer eligible for the Ixchiq vaccine in La Réunion and Mayotte.

UKHSA Publishes First Priority Pathogens List to Guide Pandemic Preparedness

Flu Season 2025 Reaches Highest Severity in 15 Years

Surge in Respiratory Illnesses in Germany, Grippe Cases Rise Sharply Among Children

U.S. Faces Surge in Flu, COVID-19, RSV, and Norovirus Cases

CDC Issues Alert After Severe Mpox Case Detected in California

CDC Expands Bird Flu Testing After Asymptomatic Infections Found in Dairy Workers

Whooping Cough Cases Surge to Decade High in the U.S.

US Bolsters Bird Flu Vaccine Stockpile Amid Rising Infections

India Reports First Travel-Related Mpox Case; Government Emphasizes Vigilance

WHO Considers Global Health Emergency for Mpox Outbreak

UK Faces Surge in Whooping Cough Cases, 10 Infant Deaths Reported

FDA Approves Pfizer's RSV Vaccine for Seniors After Success in Late-Stage Trials